Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.In statin-treated patients, inflammation, not cholesterol, predicts cardiovascular events in those with impaired kidney function. This highlights residual inflammatory risk in chronic kidney disease patients.
Area Of Science
- Cardiovascular Medicine
- Nephrology
- Inflammation Research
Background
- Hyperlipidemia and inflammation are key drivers of atherosclerotic disease.
- Statin therapy reduces cholesterol risk but residual risk factors persist.
- The relative importance of residual cholesterol versus inflammatory risk may differ based on kidney function.
Purpose Of The Study
- To evaluate residual cholesterol and inflammatory risk as determinants of recurrent cardiovascular events and mortality.
- To stratify analyses by baseline kidney function (eGFR ≥ 60 vs. < 60 mL/min/1.73 m²).
- To assess the predictive utility of hsCRP, IL-6, LDL-C, and non-HDL-C in statin-treated post-MI patients.
Main Methods
- Analysis of 9151 stable statin-treated post-MI patients from the CANTOS trial.
- Stratification by estimated glomerular filtration rate (eGFR) using CKD-EPI 2021 formula.
- Focus on high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) for inflammatory risk; LDL-cholesterol (LDL-C) and non-HDL-cholesterol (non-HDL-C) for cholesterol risk.
- Follow-up for up to 5 years (median 3.7 years).
Main Results
- In patients with eGFR ≥ 60 mL/min/1.73 m², hsCRP, IL-6, LDL-C, and non-HDL-C all predicted recurrent MACE.
- In patients with eGFR < 60 mL/min/1.73 m², only hsCRP and IL-6 significantly predicted recurrent MACE (P < 0.05).
- LDL-C and non-HDL-C did not predict MACE in patients with eGFR < 60 mL/min/1.73 m².
- hsCRP and IL-6 predicted total mortality in patients with eGFR < 60 mL/min/1.73 m², while LDL-C and non-HDL-C did not.
Conclusions
- Among statin-treated atherosclerosis patients with impaired kidney function, residual inflammatory risk significantly predicts recurrent cardiovascular events.
- Inflammatory markers (hsCRP, IL-6) are crucial for risk stratification in chronic kidney disease patients.
- These findings support the development of novel anti-inflammatory therapies for high-risk cardiovascular populations.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...